Drug Delivery
-
Novozymes Biopharma wins technology innovation award
Novozymes Biopharma has received the 2012 Drug Delivery Partnerships (DDP) Technology Innovation award for the company’s half-life extension platform. The award recognizes the most exciting delivery technology of the year.
Drug Delivery | 08 February 2012
-
Bio-Images and Medimetrics partner to deliver the next generation of smart pill technology
IntelliCap set to speed up clinical research as part of innovative drug delivery package.
Drug Delivery | 25 October 2011
-
Bio-Images Group expands its presence in Asia Pacific
To exhibit at AusBiotech 2011 in Adelaide, South Australia this October.
Drug Delivery | 10 October 2011
-
Agilent Technologies and Chungnam National University collaborate to further glycomics research
Agilent Technologies Inc and Chungnam National University announced an agreement to develop new applications, methods, technologies and software tools in the field of glycomics, the study of complex sugars. The university aims to identify and deve…
Drug Delivery | 23 August 2011
-
Lipocine Chairman awarded “Order of the Rising Sun†by Japanese government
Lipocine announces that Dr William Higuchi, Lipocine co-founder and Chairman of the Board, was awarded the ‘Order of The Rising Sun’ by the Japanese Government for “contribution to the development of Japanese pharmaceutics and pharmaceutical ch…
Drug Delivery | 07 July 2011
-
Pharmigene secures patents to warfarin dosage predictor
Pharmigene announced it has been granted patents in Europe, Japan, New Zealand, Mexico, Singapore, and Taiwan. The patents are related to methods used to predict dosage of the widely-prescribed anti-coagulant drug warfarin based on genetic variations…
Drug Delivery | 03 June 2011
-
Sanofi-aventis signs new agreement with WHO to fight neglected tropical diseases
Further $ 25 million donation raises prospects of eliminating sleeping sickness
Drug Delivery | 09 March 2011
-
Rare anti-influenza antibodies
Scientists have identified a new, highly conserved molecular target on the influenza A virus and demonstrated that human antibodies against this target are protective in animal models of seasonal and highly-pathogenic avian influenza. The work wa…
Drug Delivery | 01 July 2010
-
Novartis Receives Approval for Organ Rejection Prevention Drug
The US Food and Drug Administration (FDA) has approved Zortress (everolimus) oral tablets for the prevention of organ rejection of kidney transplants in adult patients at low-to-moderate immunologic risk. The drug is to be given in combination with r…
Drug Delivery | 27 May 2010
-
Roche and OSI Pharmaceuticals Gain Approval for Cancer Treatment
Roche and OSI Pharmaceuticals have gained US Food and Drug Administration (FDA) approval for the use of Tarceva as a maintenance treatment for non-small cell lung cancer. The FDA's decision comes despite an earlier negative opinion from its advis…
Drug Delivery | 26 May 2010
